最高の膵癌医師 - トップ113名の医師

Bülent Karagöz教授は膵臓癌を専門とし、33年の経験の経験とアナドル医療センターにおける900件以上の処置実績を有しています。

• 腫瘍生物学、免疫学、および分子標的がん治療の専門家
• イスタンブール・オカン大学医学部教授
• がん研究に関する40本以上の論文を発表
• 主要教育病院における腫瘍内科部長
• トルコ腫瘍内科学会会員

エダ・タンリクル医師は、アナドル医療センターで腫瘍内科を専門とし、膵臓癌の治療において21年の経験の経験を有しています。

• マルマラ大学にて腫瘍内科の研修を修了
• アナドル医療センターの腫瘍委員会メンバー
• 腫瘍学における国際臨床研究に参加
• ハイダルパシャ・ヌムネ研修研究病院にて腫瘍内科部長を歴任

1,100件以上のがん治療を実施 – ムスタファ・ソラク医師は、ヒサール・ホスピタル・インターコンチネンタルにおいて、膵臓がんを含む消化器がんを専門としています。

• 20年の経験 の腫瘍内科における経験
• ハジェテペ大学がん研究所にてフェローシップ研修を修了
• 世界的な権威であるMDアンダーソンがんセンターに勤務
• 乳がん、肺がん、消化器がんを専門とする

Kivanc Derya Peker教授は、膵臓がんおよび胃がん手術を400件以上執刀しており、メイヨー・クリニックでの高度研修と肝胆膵外科領域のリーダーシップを有しています。

• 消化器外科における22年の経験の臨床経験
• Dr. Sadi Konuk病院における肝胆膵外科ユニットの創設者
• 一般外科および消化器外科レジデントへの肝胆膵手術手技の指導
• 膵臓・胆嚢・肝臓疾患外科を専門とする
• メイヨー・クリニック研修のためのトルコ外科学会奨学金受賞者

低侵襲膵臓癌手術のパイオニアとして、腹腔鏡手術を12,000件以上執刀。権威あるDr. Ballesta腹腔鏡センターの創設者兼ディレクター。

• 消化器・膵臓外科を専門とする46年の経験の経験
• 精度向上のためのロボット支援ダ・ヴィンチ手術を実施
• 高度腹腔鏡技術において世界中の外科医を指導
• 外科的質においてIFSO認定卓越センターを取得
• 腹部外科に関する多数の論文を執筆

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

シャロン・ペレス医師は消化管腫瘍を専門とし、ロンドンの名高いロイヤル・マーズデン癌センターで研鑽を積みました。

• 膵癌手術およびウィップル手術の専門家
• 国際共同研究による臨床研究を実施
• 腹腔内温熱化学療法（HIPEC）および免疫療法などの高度治療を提供
• 腫瘍学の先進施設であるスーラスキー医療センター（イチロフ）に勤務

Pfaffenbach教授は、ゾーリンゲン大学病院の消化器内科・腫瘍科長として、年間9,000件以上の内視鏡的介入を行っています。

• 内臓悪性腫瘍を専門とする
• 34年の経験の外科的および臨床的実務経験
• 腸管腫瘍学センター長
• 130本以上の論文著者
• 欧州消化器病学会会員

パストラーナ医師は、ガレニア病院において膵臓癌を専門とする外科腫瘍学の資格認定医です。

• 外科腫瘍学における豊富な研修歴を持ち、Conacemにより資格認定を取得
• メキシコ腫瘍学会（SMEO）会員
• 2020年よりアナワク大学にて大学教員として勤務

メリムスキー教授は膵臓癌を専門とし、スーラスキー医療センターにて数十年にわたる腫瘍学の経験を有しています。

• 軟部組織および骨腫瘍学の専門歴 41年の経験 年以上
• フェルスタイン医学研究センター上席研究員
• 欧州臨床腫瘍学会（ESMO）会員
• スーラスキー医療センター腫瘍科外来部門長

Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.

3,600件以上の膵臓手術を実施 – ファルコーニ教授はサン・ラッファエーレ病院において臓器温存術式を専門としています。

• 消化器腫瘍学におけるの経験
• IRCCS オスペダーレ・サン・ラッファエーレ 膵臓外科部長
• 日本、スペイン、ドイツ、スウェーデンの国際的な主要病院にて研鑽を積む
• 膵臓治療に関する330本以上の論文を発表
• 国際膵臓関連学会5団体の会員

Dr. Asawadech Sanbua

Medical Radiation​ Oncologist

• Passed palliative care training at the Karunrak Center. Khon Kaen University
  
   
• Certificate of oncotherm
  
   
• Expert in treating cancer with oncothermia machines (or hyperthermia machine) 5 years experience.
  
   
• 14 years of experience working in radiotherapy. Able to plan treatment (Planning 2D, 3D, IMRT, VMAT)
  
   
• Can provide chemical treatment, Chemotherapy, targeted drugs therapy) Immunotherapy (Immunotherapy) 

Dr. Jaroslav Tvaruzek is a specialist in robotic surgery. Dr. Tvaruzek is a leading certified expert by Intuitive Surgical - the American produced of the original Da Vinci robots. The doctor is a member of Association of Aesthetic Medicine and Association of Bariatric Surgery.

Dr. Tvaruzek heads the Center of Robotic Surgery located in the St. Zdislava Hospital (the Czech Republic). The doctor has performed over 3,500 robotic surgeries for his practice. Among them are:

• prostatectomy with preservation of the erectile function
• transoral surgeries (removal tumors of the nasopharynx, larynx, trachea, mouth)
• thyroidectomy
• nephrectomy
• bariatric surgeries (surgical treatment of obesity).

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations